BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1279 related articles for article (PubMed ID: 15629605)

  • 1. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.
    Vasanthan A; Mitsumori M; Park JH; Zhi-Fan Z; Yu-Bin Z; Oliynychenko P; Tatsuzaki H; Tanaka Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):145-53. PubMed ID: 15629605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients.
    Franckena M; Lutgens LC; Koper PC; Kleynen CE; van der Steen-Banasik EM; Jobsen JJ; Leer JW; Creutzberg CL; Dielwart MF; van Norden Y; Canters RA; van Rhoon GC; van der Zee J
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):242-50. PubMed ID: 18990505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.
    Franckena M; Stalpers LJ; Koper PC; Wiggenraad RG; Hoogenraad WJ; van Dijk JD; Wárlám-Rodenhuis CC; Jobsen JJ; van Rhoon GC; van der Zee J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1176-82. PubMed ID: 17881144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia.
    Franckena M; Fatehi D; de Bruijne M; Canters RA; van Norden Y; Mens JW; van Rhoon GC; van der Zee J
    Eur J Cancer; 2009 Jul; 45(11):1969-78. PubMed ID: 19361982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study.
    Maluta S; Dall'Oglio S; Romano M; Marciai N; Pioli F; Giri MG; Benecchi PL; Comunale L; Porcaro AB
    Int J Hyperthermia; 2007 Aug; 23(5):451-6. PubMed ID: 17701536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma.
    Westermann AM; Jones EL; Schem BC; van der Steen-Banasik EM; Koper P; Mella O; Uitterhoeve AL; de Wit R; van der Velden J; Burger C; van der Wilt CL; Dahl O; Prosnitz LR; van der Zee J
    Cancer; 2005 Aug; 104(4):763-70. PubMed ID: 15968685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries.
    Ohno T; Nakano T; Kato S; Koo CC; Chansilpa Y; Pattaranutaporn P; Calaguas MJ; de Los Reyes RH; Zhou B; Zhou J; Susworo R; Supriana N; Dung TA; Ismail F; Sato S; Suto H; Kutsutani-Nakamura Y; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1522-9. PubMed ID: 17919839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky".
    Sreenivasa G; Hildebrandt B; Kümmel S; Jungnickel K; Cho CH; Tilly W; Böhmer D; Budach V; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1159-67. PubMed ID: 16979843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature data analysis for 22 patients with advanced cervical carcinoma treated in Rotterdam using radiotherapy, hyperthermia and chemotherapy: a reference point is needed.
    Fatehi D; van der Zee J; van der Wal E; Van Wieringen WN; Van Rhoon GC
    Int J Hyperthermia; 2006 Jun; 22(4):353-63. PubMed ID: 16754355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
    Dobrowsky W; Huigol NG; Jayatilake RS; Kizilbash NI; Okkan S; Kagiya VT; Tatsuzaki H
    Radiother Oncol; 2007 Jan; 82(1):24-9. PubMed ID: 17161478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
    Tacev T; Vacek A; Ptácková B; Strnad V
    Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes.
    Ohguri T; Imada H; Yahara K; Morioka T; Nakano K; Terashima H; Korogi Y
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):128-35. PubMed ID: 18513887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
    Strnad V; Geiger M; Lotter M; Sauer R
    Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperthermia combined with external radiation therapy in primary non-small cell lung cancer with direct bony invasion.
    Sakurai H; Hayakawa K; Mitsuhashi N; Tamaki Y; Nakayama Y; Kurosaki H; Nasu S; Ishikawa H; Saitoh JI; Akimoto T; Niibe H
    Int J Hyperthermia; 2002; 18(5):472-83. PubMed ID: 12227932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.